C4BPα, or Complement Component 4 Binding Protein Alpha, is a regulatory component of the classical and lectin pathways of the complement system. Activators of C4BPα are crucial in modulating the complement cascade, ensuring that the activation is controlled and does not cause unintended damage to host tissues. One class of activators operates through the enhancement of the protein's cofactor activity for the serine protease Factor I, which leads to the inactivation of C4b. These molecules ensure a heightened state of regulation, maintaining the delicate balance between complement activation and inhibition. Another set of activators affects the protein's ability to bind to cell surface receptors, such as heparin sulfate proteoglycans, thus enhancing the localization of C4BPα to sites where complement regulation is acutely needed. This localization is instrumental in protecting self-cells from autologous attack, fine-tuning the immune response to be robust against pathogens while being benign to the body's own cells.
Furthermore, specific activators of C4BPα may influence the protein's interaction with other complement inhibitors like Factor H, or modulate its role.. By increasing the stability or the affinity of C4BPα for these convertase complexes, the activators play a significant role in curtailing the amplification of the complement response. The action of these chemicals ensures that C4BPα can effectively limit the extent of complement activation.
SEE ALSO...
Items 1 to 10 of 18 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
A bioactive compound that modulates various molecular targets, potentially affecting immune system gene expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels, thus indirectly enhancing C4BPα activity via PKA, which can affect C4BPα mediated control of complement activation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
A polyphenol that may impact gene expression through sirtuin activation and influence on inflammatory pathways. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $56.00 $156.00 $270.00 $665.00 | 37 | |
PGE2 binds to its G-protein-coupled receptors, leading to increased cAMP production and PKA activation. This series of events can enhance the regulatory function of C4BPα in the complement system. | ||||||
Ibudilast | 50847-11-5 | sc-203080 | 10 mg | $214.00 | 1 | |
Ibudilast raises intracellular cAMP levels, potentially enhancing C4BPα function by similar mechanisms as Forskolin and PGE2, supporting its role in complement regulation. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $47.00 | ||
An essential mineral that plays a role in immune function and may influence gene expression. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Rolipram inhibits phosphodiesterase 4, increasing cAMP levels and promoting PKA activity, which may enhance the regulatory role of C4BPα in the complement pathway. | ||||||
Zardaverine | 101975-10-4 | sc-201208 sc-201208A | 5 mg 25 mg | $88.00 $379.00 | 1 | |
Zardaverine is another phosphodiesterase inhibitor that increases cAMP concentration, indirectly enhancing C4BPα activity through the PKA signaling pathway. | ||||||
L-Ascorbic acid, free acid | 50-81-7 | sc-202686 | 100 g | $45.00 | 5 | |
A compound that can affect immune system function and potentially modulate gene expression. | ||||||
Iloprost | 78919-13-8 | sc-205349 sc-205349A | 500 µg 1 mg | $155.00 $269.00 | ||
Iloprost is a synthetic analog of prostacyclin PGI2 that increases cAMP in cells, indirectly enhancing C4BPα activity through PKA, affecting the complement system. |